| Trial Identifier: | D5674C00001 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT03645421 |
| Start Date: | August 2018 |
| Primary Completion Date: | January 2019 |
| Study Completion Date: | January 2019 |
| Condition: | Diabetes: Type 2 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| Japanese Translation |
| Country | Location |
|---|---|
| Japan | Chuo-ku, Japan, 103-0027 |
| Japan | Chuo-ku, Japan, 104-0031 |
| Japan | Shinjuku-ku, Japan, 160-0008 |
| Japan | Shinjuku-ku, Japan, 162-0053 |
| Japan | Suita-shi, Japan, 565-0853 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company